Site Search
410 result(s) found for “ adaptive therapy”
-
Novel Therapy Shows Promise for Lung Cancer Patients with Rare EGFR Mutation
Amivantamab, an EGFR-MET biospecific antibody, has already received Breakthrough Therapy Designation by the FDA
-
Researchers Investigating TIL Therapy Feasibility in Head and Neck Squamous Cell Cancer
Dr. Kedar Kirtane is the principal investigator for a Phase IB clinical trial focusing on Squamous Cell Cancer Tumor-Infiltrating Lymphocytes (TIL).
-
Moffitt Researchers Show That Reactivity to Tumor Antigens is Important for TIL Therapy
Lung cancer study highlights challenges and opportunities for the cellular immunotherapy
-
Moffitt Study Explores Key Risk Factors To Better Personalize CAR T-Cell Therapy
The study analyzed ide-cel to help physicians intervene and reduce toxicities in multiple myeloma patients
-
Moffitt Study Finds Promising First Evidence of Targeted Therapy for NRAS-Mutant Melanoma
Researchers uncover a new way to help the immune system fight aggressive skin cancer
-
Next-Gen Cell Therapy Shows Lasting Remission for Older Adults with Aggressive Leukemia
Recently approved obe-cel continues to deliver high remission rates and durable responses in patients once considered too high-risk for immunotherapy
-
23MA016 T cell engineering: Engineered Isoforms of Humanin to Improve T-Cell Therapy
Download PDFHumanin is a mitochondrial-derived peptide that plays a crucial role in many biological processes including promotion of anti-apoptotic...
-
In Silico Trial Estimates Personalized Radiation Therapy Dose in Head and Neck Cancer
By means of this unique in silico trial, we demonstrate a potential method to use historical clinical observations in conjunction with...
-
Innovative Combination Therapy Shows Promise for Bladder Cancer Patients Unresponsive to Standard Treatment
CORE-001 trial demonstrates efficacy of oncolytic virus and immune checkpoint inhibitor in treating non-muscle invasive bladder cancer
-
Moffitt Cancer Center Study Suggests More Could Benefit from CAR T-Cell Therapy
The largest report of commercial CAR T therapy for lymphoma demonstrates its effectiveness even in patients that would not have been eligible for...